SOMNOMED LIMITED (SOM)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SOM - SOMNOMED LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -2.64
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.43

20 Dec
2024

0.000

OPEN

$0.43

0.000

HIGH

$0.43

35,031

LOW

$0.43

OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . AYA . BB1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CVB . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . TRJ . UBI . VTI .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-10.1
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx91.7 M
Book Value Per Share xxxxxxxxxxxxxxx20.8
Net Operating Cash Flow xxxxxxxxxxxxxxx-6.3 M
Net Profit Margin xxxxxxxxxxxxxxx-13.36 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-36.31 %
Return on Invested Capital xxxxxxxxxxxxxxx-26.47 %
Return on Assets xxxxxxxxxxxxxxx-18.51 %
Return on Equity xxxxxxxxxxxxxxx-36.31 %
Return on Total Capital xxxxxxxxxxxxxxx-17.03 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-7.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx3 M
Long Term Debt xxxxxxxxxxxxxxx4 M
Total Debt xxxxxxxxxxxxxxx7 M
Goodwill - Gross xxxxxxxxxxxxxxx6 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx16 M
Price To Book Value xxxxxxxxxxxxxxx1.21

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx5.3 M
Capex % of Sales xxxxxxxxxxxxxxx5.83 %
Cost of Goods Sold xxxxxxxxxxxxxxx42 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx58 M
Research & Development xxxxxxxxxxxxxxx1 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Wilsons

04/12/2024

1

Upgrade to Overweight from Market Weight

$0.45

4.65%

SomnoMed is upgraded to Overweight from Market Weight with a higher target price of 45c by Wilsons.

Management announced an upgrade in FY25 guidance to around $105m in revenue and over $7m in earnings at the AGM, resulting from "de-risking" manufacturing in Manila, which freed up a 30% increase in sustainable capacity.

The analyst explains that this intervention has allowed the company to meet the order backlog and recapture previously lost customers from 2H24.

Wilsons sees the positive flow-on impacts as enabling SomnoMed to consider winding back its promotions and possibly implementing a slight price rise in 2H25.

Overweight rated. Target price: 45c.

FORECAST
Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -0.40 cents.
Wilsons forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.50 cents.
Access Extra Coverage Research History >

SOM STOCK CHART

FNArena News on SOM

1
In Case You Missed It – BC Extra Upgrades & Downgrades – 06-12-24

Dec 06 2024 - Weekly Reports
2
Australian Broker Call *Extra* Edition – Dec 04, 2024

Dec 04 2024 - Daily Market Reports
3
Australian Broker Call *Extra* Edition – Oct 31, 2024

Oct 31 2024 - Daily Market Reports
4
Australian Broker Call *Extra* Edition – Sep 04, 2024

Sep 04 2024 - Daily Market Reports
5
Australian Broker Call *Extra* Edition – Aug 01, 2024

Aug 01 2024 - Daily Market Reports

Latest Medical Equipment & Devices News

1
Diagnostic Imaging Radiates Opportunity

Dec 18 2024 - Small Caps
2
ResMed’s Bounce-Back Complete

Oct 29 2024 - Australia
3
Dr Boreham’s Crucible: Pro Medicus

Sep 04 2024 - Australia
4
Pro Medicus: Don’t Stop Me Now

Aug 20 2024 - Technicals
5
Dr Boreham’s Crucible: Blinklab

May 20 2024 - Small Caps
6
ResMed Silences The Doubters

Apr 29 2024 - Australia
7
Dr Boreham’s Crucible: 4D Medical

Apr 23 2024 - Small Caps
8
Uptrend Resumed For ResMed

Mar 19 2024 - Technicals
9
Dr Boreham’s Crucible: Cochlear

Feb 28 2024 - Australia
10
Rudi Interviewed: Ongoing Potential In Technology & Growth

Feb 19 2024 - Rudi's View